Global Acute Agitation And Aggression Treatment Market Size By Product, By Application, By Geographic Scope And Forecast
Published on: 2024-08-03 | No of Pages : 320 | Industry : latest updates trending Report
Publisher : MIR | Format : PDF&Excel
Global Acute Agitation And Aggression Treatment Market Size By Product, By Application, By Geographic Scope And Forecast
Acute Agitation And Aggression Treatment Market Size And Forecast
Acute Agitation And Aggression Treatment Market size was valued at USD 2.9 Billion in 2018 and is projected to reach USD 4.2 Billion by 2026, growing at a CAGR of 4.80% from 2019 to 2026.
The increased burden of mental disease and growing agitation in patients raised focus on awareness of agitation and aggression, and continuous research on developing a novel treatment for agitation is the factor driving the market growth of the Global Acute Agitation and Aggression Treatment Market. The Global Acute Agitation And Aggression Treatment Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Acute Agitation And Aggression Treatment Market Definition
Acute agitation is a state of discomfort or tension with or without excessive motor activity. Aggression refers to a behavioral expression of extreme arousal that can harm oneself or others. Excitement and aggression are typical in the context of mental health care and require serious attention from staff if detected. Management of acute agitation and aggression has evolved over the years to prioritize the rapid improvement of symptoms and avoidance of more restrictive interventions such as isolation and suppression.
In recent years, one obstacle that has made treatment planning more complex is drug deficiency. The shortage of medicines has forced prescribers to use alternatives that they may not be conditioned to. This is especially problematic during acute arousal and aggression, where timely intervention is paramount. Throughout the article, clinical cases are used to explore treatment options and help readers optimize treatment, despite the barriers often encountered in practice.
Manufacturers are increasing the production of benzodiazepines for the quick treatment of acute agitation in the emergency room. Benzodiazepines are known to sedate undifferentiated patients without overt delirium or psychosis. Yet, benzodiazepines are at risk of causing paradoxical reactions in patients, mainly the elderly and adolescents. Benzodiazepines are well tolerated and have rare side effects.
Global Acute Agitation And Aggression Treatment Market Overview
The primary factor driving the market growth is the increased burden of mental disease and growing agitation in patients raised focus on awareness of agitation and aggression, and continuous research on developing a novel treatment for agitation. Antipsychotics typically induce sedation at sufficiently high doses. Haloperidol, a very potent butyrophenone, has been used routinely as an intramuscular injection for many patients’ agitation and aggressive behaviors in the emergency department.
Droperidol, another antipsychotic drug in the butyrophenone class, is not approved by the U.S. Food and Drug Administration for psychotic disorders but has been used to sedation agitated patients in the emergency room. Moreover, a robust development pipeline coupled with the activity of the manufacturers in launch and collaborations is projected to boost the segment growth. Furthermore, the growing burden of risk factors agitation and aggression such as neurological disorders is increasing the market growth of the Global Acute Agitation And Aggression Treatment Market.
Non-pharmacological interventions’ preferred non-pharmacological goals are to reduce fear, distress, and anxiety, reduce pain, and provide patients with a sense of control. Self-stigmatization refers to negative attitudes, including inner shame, that people with mental illness have about their condition are the factors hampering the market growth of the Global Market.
Global Acute Agitation And Aggression Treatment Market Segmentation Analysis
The Global Acute Agitation And Aggression Treatment Market is Segmented on the basis of Product, Application, And Geography.
Acute Agitation And Aggression Treatment Market, By Product
• Oral• Intramuscular Injection• Others
Based on Product, the market is segmented into Oral, Intramuscular Injection, and Others. the oral segment holds a large number of shares in the market because of the advised use of agitation treatment drugs in oral form, which is the factor that boosts the market growth of the Market.
Acute Agitation And Aggression Treatment Market, By Application
• Hospitals & Ambulatory Surgical Centers• Psychiatric Care Facilities• Others
Based on the Application, the market is segmented into Hospitals & Ambulatory Surgical Centers, Psychiatric Care Facilities, And Others. Hospitals & Ambulatory Surgical Centers segment holds a large number of shares in the market because the increasing number of agitation patients in the hospital is the factor that boosts the market growth of the Global Market.
Acute Agitation And Aggression Treatment Market, By Geography
• North America• Europe• Asia Pacific• Rest of the World
Based on Geography, the Global Acute Agitation And Aggression Treatment Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. the North American region holds a large number of shares in the market because of the increasing number of cases regarding a mental health conditions, which boosts the market growth of the Global Acute Agitation And Aggression Treatment Market.
Key Players
The “Global Acute Agitation And Aggression Treatment Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Eli Lilly and Company, Pfizer, Ono Pharmaceutical, Otsuka Holdings, GlaxoSmithKline, Bristol-Myers Squibb, Johnson & Johnson, and H. Lundbeck A/S.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
Report Scope
REPORT ATTRIBUTES | DETAILS |
---|---|
STUDY PERIOD | 2015-2026 |
BASE YEAR | 2018 |
FORECAST PERIOD | 2019-2026 |
HISTORICAL PERIOD | 2015-2017 |
UNIT | Value (USD Billion) |
KEY COMPANIES PROFILED | Eli Lilly and Company, Pfizer, Ono Pharmaceutical, Otsuka Holdings, GlaxoSmithKline, Bristol-Myers Squibb, Johnson & Johnson, and H. Lundbeck A/S. |
SEGMENTS COVERED | • By Product |
CUSTOMIZATION SCOPE | Free report customization (equivalent up to 4 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope |
Top Trending Reports
Research Methodology of Market Research
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support
Customization of the Report
• In case of any please connect with our sales team, who will ensure that your requirements are met.